Gå til hovedinnhold

Vitenskapelige studier

Fagfellevurderte publikasjoner fra uavhengige forskere som undersøker tyrosin i urin og relaterte aminosyremetabolitter.

Viktig: Studiene som er oppført nedenfor er uavhengige tredjepartspublikasjoner. Inkluderingen på denne siden er kun for informasjonsformål og utgjør ingen produktpåstander fra Advanced Genetics eller CCI REAGENT.

Publisert forskning

Følgende publikasjoner utforsker rollen til tyrosin i urin og relaterte metabolitter i ulike kliniske sammenhenger.

1

Evidence of abnormal tyrosine phosphorylated proteins in the urine of patients with bladder cancer

PubMed
2

Correlation between stage of prostate cancer and tyrosine and tryptophan in urine samples measured electrochemically

ScienceDirect
3

Early diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteins

Nature
4

Urinary tyrosine-phosphorylated proteins: a non-invasive marker for diagnosis, prognosis and follow-up for bladder cancer

MirrorsMed
5

Tyrosine, Phenylalanine, and Tryptophan in Gastroesophageal Malignancy

AACR Journals
6

Application of metabolomics in the diagnosis of breast cancer

PubMed Central
7

Evaluation of aromatic amino acids as potential biomarkers in breast cancer by Raman spectroscopy

Nature Scientific Reports
8

Review and Comparison of Cancer Biomarker Trends in Urine as a Basis for New Diagnostic Pathways

MDPI Cancers
9

Urinary Metabonomic Study on Colorectal Cancer

ACS Publications
10

Urinary Metabolites as Biomarkers for Diagnosis of Breast Cancer

Journal of Breast Disease
11

Metabonomics studies on serum and urine of patients with breast cancer using 1H-NMR spectroscopy

Oncotarget
12

Raman Spectroscopy Reveals Abnormal Changes in the Urine Composition of Prostate Cancer

Wiley
13

Detection of tyrosine and monitoring tyrosinase activity using an enzyme cascade-triggered colorimetric reaction

PubMed Central
14

Tyrosine crystals in urine

Medical Labs

Klar til å evaluere?

Registrer din interesse — vårt partnerteam vil følge opp med fullstendig produktdokumentasjon, regulatoriske filer og distribørvilkår. Ingen forpliktelse. Full åpenhet.